253 related articles for article (PubMed ID: 26473484)
1. Perceptions and Attitudes of Egyptian Health Professionals and Policy-Makers towards Pharmaceutical Sales Representatives and Other Promotional Activities.
Kamal S; Holmberg C; Russell J; Bochenek T; Tobiasz-Adamczyk B; Fischer C; Tinnemann P
PLoS One; 2015; 10(10):e0140457. PubMed ID: 26473484
[TBL] [Abstract][Full Text] [Related]
2. Characterizing the interaction between physicians, pharmacists and pharmaceutical representatives in a middle-income country: A qualitative study.
Hajjar R; Bassatne A; Cheaito MA; Naser El Dine R; Traboulsy S; Haddadin F; Honein-AbouHaidar G; Akl EA
PLoS One; 2017; 12(9):e0184662. PubMed ID: 28898296
[TBL] [Abstract][Full Text] [Related]
3. Influence of pharmaceutical promotion on prescribers in Jordan.
Altawalbeh SM; Ibrahim IA; Al-Shatnawi SF
Int J Clin Pharm; 2020 Apr; 42(2):744-755. PubMed ID: 32140917
[TBL] [Abstract][Full Text] [Related]
4. Physicians' perceptions of medical representative visits in Yemen: a qualitative study.
Al-Areefi MA; Hassali MA; Ibrahim MI
BMC Health Serv Res; 2013 Aug; 13():331. PubMed ID: 23962304
[TBL] [Abstract][Full Text] [Related]
5. Pharmacist-industry relationships.
Saavedra K; O'Connor B; Fugh-Berman A
Int J Pharm Pract; 2017 Dec; 25(6):401-410. PubMed ID: 28097713
[TBL] [Abstract][Full Text] [Related]
6. Influence of Pharmaceutical Company Engagement Activities on the Decision to Prescribe: A Pilot Survey of UK Rare Disease Medicine Prescribers.
Jandhyala R
Pharmaceut Med; 2020 Apr; 34(2):127-134. PubMed ID: 32048216
[TBL] [Abstract][Full Text] [Related]
7. Reconciling a "pleasant exchange" with evidence of information bias: A three-country study on pharmaceutical sales visits in primary care.
Reynolds E; Guénette L; Lexchin J; Cassels A; Wilkes MS; Durrieu G; Beaulieu MD; Mintzes B
Health Policy; 2018 Mar; 122(3):250-255. PubMed ID: 29395543
[TBL] [Abstract][Full Text] [Related]
8. Collaborative prescribing: a qualitative exploration of a role for pharmacists in mental health.
Wheeler A; Crump K; Lee M; Li L; Patel A; Yang R; Zhao J; Jensen M
Res Social Adm Pharm; 2012; 8(3):179-92. PubMed ID: 21831724
[TBL] [Abstract][Full Text] [Related]
9. Stakeholders' views on granting prescribing authority to pharmacists in Nigeria: a qualitative study.
Auta A; Strickland-Hodge B; Maz J
Int J Clin Pharm; 2016 Aug; 38(4):960-7. PubMed ID: 27194098
[TBL] [Abstract][Full Text] [Related]
10. What patients think about promotional activities of pharmaceutical companies in Turkey.
Semin S; Güldal D; Ozçakar N; Mevsim V
Pharm World Sci; 2006 Aug; 28(4):199-206. PubMed ID: 17066242
[TBL] [Abstract][Full Text] [Related]
11. Knowledge, beliefs and attitudes of physicians in low and middle-income countries regarding interacting with pharmaceutical companies: a systematic review.
Lotfi T; Morsi RZ; Rajabbik MH; Alkhaled L; Kahale L; Nass H; Brax H; Fadlallah R; Akl EA
BMC Health Serv Res; 2016 Feb; 16():57. PubMed ID: 26883210
[TBL] [Abstract][Full Text] [Related]
12. The attitude and acceptability towards medical promotional tools and their influence on physicians' prescribing practices in Jordan and Iraq: a cross-sectional study.
Ali KE; Naser AY; Al-Rousan R; Alwafi H; AbuAlhommos AK; Alsairafi ZK; Salawati EM; Samannodi M; Dairi MS
BMC Health Serv Res; 2022 Jan; 22(1):105. PubMed ID: 35078461
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012.
Vilhelmsson A; Davis C; Mulinari S
PLoS Med; 2016 Jan; 13(1):e1001945. PubMed ID: 26812151
[TBL] [Abstract][Full Text] [Related]
14. Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications.
Fadare JO; Oshikoya KA; Ogunleye OO; Desalu OO; Ferrario A; Enwere OO; Adeoti A; Sunmonu TA; Massele A; Baker A; Godman B
Hosp Pract (1995); 2018 Apr; 46(2):77-87. PubMed ID: 29426263
[TBL] [Abstract][Full Text] [Related]
15. Pharmacists' and physicians' perception and exposure to drug promotion: A Saudi study.
Zaki NM
Saudi Pharm J; 2014 Dec; 22(6):528-36. PubMed ID: 25561865
[TBL] [Abstract][Full Text] [Related]
16. Perceptions of the provision of drug information, pharmaceutical detailing and engagement with non-personal promotion at a large physicians network: a mixed-methods study.
Hincapie A; Schlosser E; Damachi U; Neff E; Llambi L; Groves K; MacKinnon NJ
BMJ Open; 2021 Jan; 11(1):e041098. PubMed ID: 33462098
[TBL] [Abstract][Full Text] [Related]
17. Value of services provided by pharmaceutical companies: perceptions of physicians and pharmaceutical sales representatives.
Gaedeke RM; Tootelian DH; Sanders EE
Health Mark Q; 1999; 17(1):23-31. PubMed ID: 11066720
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical drug marketing strategies and tactics: a comparative analysis of attitudes held by pharmaceutical representatives and physicians.
Parker RS; Pettijohn CE
Health Mark Q; 2005; 22(4):27-43. PubMed ID: 16597582
[TBL] [Abstract][Full Text] [Related]
19. The role of clinical pharmacists as perceived by Egyptian physicians.
Sabry NA; Farid SF
Int J Pharm Pract; 2014 Oct; 22(5):354-9. PubMed ID: 24467490
[TBL] [Abstract][Full Text] [Related]
20. Effect of legislative changes in drug promotion on medical students: questionnaire survey.
Vuorenkoski L; Valta M; Helve O
Med Educ; 2008 Dec; 42(12):1172-7. PubMed ID: 19120947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
